Clinical Trial Update: A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial in Type 2 diabetes completed to assess safety and efficacy of ASP1941 in combination with an α-glucosidase inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP1941
• α-glucosidase inhibitor

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED